Methylprednisolone is available under several trade names, including Medrol, Solu-Medrol, and Depo-Medrol [1][2]. These formulations are used to treat a variety of inflammatory and autoimmune conditions [1][3].
What conditions does methylprednisolone treat?
Methylprednisolone is prescribed for conditions such as asthma, allergies, arthritis, inflammatory bowel disease, and certain skin disorders [1][3]. It is also used to manage symptoms associated with multiple sclerosis and certain types of cancer [1].
What are the different forms of methylprednisolone?
Methylprednisolone comes in oral tablets (Medrol), intravenous or intramuscular injections (Solu-Medrol), and long-acting intramuscular injections (Depo-Medrol) [1][2]. The choice of formulation depends on the condition being treated and the desired speed and duration of action [1][4].
How does methylprednisolone work?
As a corticosteroid, methylprednisolone reduces inflammation by suppressing the immune system's response. It works by decreasing the release of inflammatory substances in the body [1][3].
What are the side effects of methylprednisolone?
Common side effects can include mood changes, increased appetite, weight gain, and difficulty sleeping. More serious side effects, particularly with long-term use, can involve bone thinning, increased risk of infection, elevated blood sugar, and adrenal suppression [1][3].
When does methylprednisolone patent exclusivity expire?
Information on specific patent expiry dates for methylprednisolone trade names can be found on DrugPatentWatch.com [5]. The original patents for methylprednisolone have long expired, allowing for the availability of generic versions. However, patents may exist for specific formulations or delivery methods.